Agency Forms Undergoing Paperwork Reduction Act Review, 25316-25317 [E7-8641]

Download as PDF 25316 Federal Register / Vol. 72, No. 86 / Friday, May 4, 2007 / Notices the services of a expert in dose reconstruction, an option provided for under 42 CFR § 83.9(c)(2)(iii). The petitioner would assume the financial burden of purchasing such services at their option. In such cases, HHS estimates a report by such an expert may cost between $640 and $6,400, depending on the scope of the petition and access to relevant information. This is based on an estimate of costs of $80 per hour for contractual services by a health physicist, who NIOSH estimates would be employed within a range of Form name& number (CFR reference) Respondents 83.9 ........................................ 83.9 ........................................ 83.9 ........................................ 83.18 ...................................... Authorization Form ................. Petitioners using Form A ........................................................ Petitioners using Form B ........................................................ Petitioners not using Form B .................................................. Petitioners Appealing proposed decisions .............................. ................................................................................................. Dated: April 27, 2007. Maryam Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E7–8593 Filed 5–3–07; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–07–06BL] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–6974. Written comments should be received within 30 days of this notice. Proposed Project Examining the Efficacy of the HIV Testing Social Marketing Campaign for African American Women (HTSMC)— New—National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention cprice-sewell on DSK89S0YB1PROD with NOTICES eight to eighty hours to conduct and prepare a report on the required assessment. The total estimated annualized burden hours are 235. Estimate of Annualized Burden Hours Number of respondents (NCHHSTP), Coordinating Center for Infectious Diseases (CCID), Centers for Disease Control and Prevention (CDC). Background and Brief Description This project involves evaluation of the HIV Testing Social Marketing Campaign for African American Women (HTSMC), a CDC-sponsored social marketing campaign aimed at increasing HIV testing rates among young, single, African American women. The CDC has designed an efficacy study to evaluate the HTSMC and its messages under controlled conditions. The study entails selecting a sample of single African American females, ages 18 to 34, with less than 4 years of college education and collecting baseline data on their knowledge, attitudes, beliefs, intentions, and behaviors related to HIV testing. The study represents an ‘‘efficacy’’ methodology in that participants will be divided into treatment and control conditions. Participants in the treatment condition, will be exposed to campaign materials including radio advertisements, a billboard, and an informational booklet that will be distributed over the Internet. Thus the study participants’ exposure will occur under controlled conditions, without the distractions and variability of potential exposure in the real world. As part of the advertisement stimuli package, the billboard advertisement will appear as part of the online log-in for each stimuli session in order to simulate the appearance of a sign. Number of responses per respondent 30 40 5 5 20 1 1 1 1 1 Average burden per respondent (in hours) 3/60 5 5.5 45/60 3/60 Therefore, we do not estimate any additional burden for exposure to the billboard advertisement. Key outcomes related to the HTSMC will be measured in two follow-up surveys. The first follow-up survey will occur 2 weeks after the baseline survey. The second follow-up survey will occur 6 weeks after the baseline survey. Comparisons of changes in these outcomes would then be made between participants in the treatment and control conditions. Findings from this study will be used by CDC and its partners to inform current and future program activities. We expect a total of 1630 participants to complete the baseline survey. The 1630 participants who complete the baseline survey will be randomly assigned to the treatment or control condition. Eight hundred fifteen participants (the treatment condition) will be exposed to the radio ad and booklet. Of the 1630 participants who completed the baseline survey, we expect 1140 to complete the first followup survey. Of the 1140 who complete the first follow-up survey, we expect 800 to complete the second follow-up survey, which will have fewer questions than the first follow-up survey because it will only pertain to questions about behavior change and selected behavioral intentions. There are no costs to the respondents other than their time. The total estimated annual burden hours are 1,127. ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Respondents Study Screener ............................................................................................................................ Baseline survey ........................................................................................................................... Radio ad stimuli viewing .............................................................................................................. VerDate Nov<24>2008 14:51 Apr 20, 2010 Jkt 220001 PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 E:\FR\FM\04MYN1.SGM 1630 1630 815 04MYN1 Average burden per response (in hours) Responses per respondent 1 1 1 2/60. 13/60. 12/60. 25317 Federal Register / Vol. 72, No. 86 / Friday, May 4, 2007 / Notices ESTIMATED ANNUALIZED BURDEN HOURS—Continued Number of respondents Respondents Booklet reading ............................................................................................................................ Follow-Up survey 1 ...................................................................................................................... Follow-Up survey 2 ...................................................................................................................... Dated: April 29, 2007. Joan F. Karr, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: April 27, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E7–8562 Filed 5–3–07; 8:45 am] [FR Doc. E7–8641 Filed 5–3–07; 8:45 am] cprice-sewell on DSK89S0YB1PROD with NOTICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP) ‘‘Assessment of Proposed Revisions to the Youth Tobacco Survey: Impact on Measures of Youth Tobacco Use’’, Request for Applications (RFA) DP07–003 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces a meeting of the aforementioned SEP. Time and Date: 1 p.m.–3 p.m., June 7, 2007 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92– 463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of scientific merit of applications received in response to ‘‘Assessment of Proposed Revisions to the Youth Tobacco Survey: Impact on Measures of Youth Tobacco Use,’’ RFA DP07–003. FOR FURTHER INFORMATION CONTACT: Denise Burton, Ph.D., Scientific Review Administrator, Office of the Chief Science Officer, CDC, 1600 Clifton Road, NE., Mailstop D72, Atlanta, GA 30333, Telephone 404–639–4641. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee 14:51 Apr 20, 2010 Jkt 220001 815 1140 800 1 1 1 15/60. 15/60. 5/60. both CDC and the Agency for Toxic Substances and Disease Registry. Dated: April 27, 2007. Elaine L. Baker, Acting Director, Management Analysis and Services Office Centers for Disease Control and Prevention. [FR Doc. E7–8591 Filed 5–3–07; 8:45 am] BILLING CODE 4163–18–P BILLING CODE 4163–18–P Centers for Disease Control and Prevention VerDate Nov<24>2008 Average burden per response (in hours) Responses per respondent DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Centers for Disease Control and Prevention (CDC) Grants for Public Health Research Dissertation, Program Announcement (PA) PAR–07–231 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention announces a meeting of the aforementioned Special Emphasis Panel. Times and Dates: 8 a.m.–5 p.m., June 14, 2007 (Closed). 8:30 a.m.–5 p.m., June 15, 2007 (Closed). Place: Doubletree Hotel Buckhead, 3342 Peachtree Road NE, Atlanta, GA 30326, telephone 404–321–1234. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘CDC Grants for Public Health Research Dissertation,’’ PA PAR–07–231. Contact Person For More Information: Juliana Cyril, Ph.D., M.P.H, Scientific Review Administrator, Office of the Chief Science Officer, CDC, 1600 Clifton Road NE., Mailstop D74, Atlanta, GA 30333, Telephone 404–639–4639. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Behavioral Assessments and Rapid HIV Testing Among African American Adolescents and Adults, Men Who Have Sex With Men and Other Groups at Risk for HIV Infection, Funding Opportunity Announcement (FOA) Number PS 07– 001, and Rapid HIV Testing in Community Mental Health Settings Serving African Americans, FOA PS 07–005 In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 12:30 p.m.–4:30 p.m., May 25, 2007 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters to be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Behavioral Assessments and Rapid HIV Testing Among African American Adolescents and Adults, Men Who Have Sex With Men and Other Groups at Risk for HIV Infection,’’ FOA Number PS 07–001, and ‘‘Rapid HIV Testing in Community Mental Health Settings Serving African Americans,’’ FOA PS 07–005. Contact Person For More Information: J. Felix Rogers, Ph.D., M.P.H., Scientific Review Administrator, Extramural Research Program Office, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, MS E:\FR\FM\04MYN1.SGM 04MYN1

Agencies

[Federal Register Volume 72, Number 86 (Friday, May 4, 2007)]
[Notices]
[Pages 25316-25317]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-8641]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-07-06BL]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail 
to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of 
Management and Budget, Washington, DC or by fax to (202) 395-6974. 
Written comments should be received within 30 days of this notice.

Proposed Project

    Examining the Efficacy of the HIV Testing Social Marketing Campaign 
for African American Women (HTSMC)--New--National Center for HIV/AIDS, 
Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Coordinating Center 
for Infectious Diseases (CCID), Centers for Disease Control and 
Prevention (CDC).

Background and Brief Description

    This project involves evaluation of the HIV Testing Social 
Marketing Campaign for African American Women (HTSMC), a CDC-sponsored 
social marketing campaign aimed at increasing HIV testing rates among 
young, single, African American women. The CDC has designed an efficacy 
study to evaluate the HTSMC and its messages under controlled 
conditions. The study entails selecting a sample of single African 
American females, ages 18 to 34, with less than 4 years of college 
education and collecting baseline data on their knowledge, attitudes, 
beliefs, intentions, and behaviors related to HIV testing. The study 
represents an ``efficacy'' methodology in that participants will be 
divided into treatment and control conditions. Participants in the 
treatment condition, will be exposed to campaign materials including 
radio advertisements, a billboard, and an informational booklet that 
will be distributed over the Internet. Thus the study participants' 
exposure will occur under controlled conditions, without the 
distractions and variability of potential exposure in the real world. 
As part of the advertisement stimuli package, the billboard 
advertisement will appear as part of the online log-in for each stimuli 
session in order to simulate the appearance of a sign. Therefore, we do 
not estimate any additional burden for exposure to the billboard 
advertisement.
    Key outcomes related to the HTSMC will be measured in two follow-up 
surveys. The first follow-up survey will occur 2 weeks after the 
baseline survey. The second follow-up survey will occur 6 weeks after 
the baseline survey. Comparisons of changes in these outcomes would 
then be made between participants in the treatment and control 
conditions. Findings from this study will be used by CDC and its 
partners to inform current and future program activities.
    We expect a total of 1630 participants to complete the baseline 
survey. The 1630 participants who complete the baseline survey will be 
randomly assigned to the treatment or control condition. Eight hundred 
fifteen participants (the treatment condition) will be exposed to the 
radio ad and booklet. Of the 1630 participants who completed the 
baseline survey, we expect 1140 to complete the first follow-up survey. 
Of the 1140 who complete the first follow-up survey, we expect 800 to 
complete the second follow-up survey, which will have fewer questions 
than the first follow-up survey because it will only pertain to 
questions about behavior change and selected behavioral intentions.
    There are no costs to the respondents other than their time. The 
total estimated annual burden hours are 1,127.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                                      Average
                                                                     Number of     Responses per    burden per
                           Respondents                              respondents     respondent     response  (in
                                                                                                      hours)
----------------------------------------------------------------------------------------------------------------
Study Screener..................................................            1630               1           2/60.
Baseline survey.................................................            1630               1          13/60.
Radio ad stimuli viewing........................................             815               1          12/60.

[[Page 25317]]

 
Booklet reading.................................................             815               1          15/60.
Follow-Up survey 1..............................................            1140               1          15/60.
Follow-Up survey 2..............................................             800               1           5/60.
----------------------------------------------------------------------------------------------------------------


    Dated: April 29, 2007.
Joan F. Karr,
Acting Reports Clearance Officer, Centers for Disease Control and 
Prevention.
[FR Doc. E7-8641 Filed 5-3-07; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.